Protein kinase C theta type
Also known as: PRKCQ, PRKCT
Function
Calcium-independent, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that mediates non-redundant functions in T-cell receptor (TCR) signaling, including T-cells activation, proliferation, differentiation and survival, by mediating activation of multiple transcription factors such as NF-kappa-B, JUN, NFATC1 and NFATC2. In TCR-CD3/CD28-co-stimulated T-cells, is required for the activation of NF-kappa-B and JUN, which in turn are essential for IL2 production, and participates in the calcium-dependent NFATC1 and NFATC2 transactivation. Mediates the activation of the canonical NF-kappa-B pathway (NFKB1) by direct phosphorylation of CARD11 on several serine residues, inducing CARD11 association with lipid rafts and recruitment of the BCL10-MALT1 complex, which then activates IKK complex, resulting in nuclear translocation and activation of NFKB1. May also play an indirect role in activation of the non-canonical NF-kappa-B (NFKB2) pathway. In the signaling pathway leading to JUN activation, acts by phosphorylating the mediator STK39/SPAK and may not act through MAP kinases signaling. Plays a critical role in TCR/CD28-induced NFATC1 and NFATC2 transactivation by participating in the regulation of reduced inositol 1,4,5-trisphosphate generation and intracellular calcium mobilization. After costimulation of T-cells through CD28 can phosphorylate CBLB and is required for the ubiquitination and subsequent degradation of CBLB, which is a prerequisite for the activation of TCR. During T-cells differentiation, plays an important role in the development of T-helper 2 (Th2) cells following immune and inflammatory responses, and, in the development of inflammatory autoimmune diseases, is necessary for the activation of IL17-producing Th17 cells. May play a minor role in Th1 response. Upon TCR stimulation, mediates T-cell protective survival signal by phosphorylating BAD, thus protecting T-cells from BAD-induced apoptosis, and by up-regulating BCL-X(L)/BCL2L1 levels through NF-kappa-B and JUN pathways. In platelets, regulates signal transduction downstream of the ITGA2B, CD36/GP4, F2R/PAR1 and F2RL3/PAR4 receptors, playing a positive role in 'outside-in' signaling and granule secretion signal transduction. May relay signals from the activated ITGA2B receptor by regulating the uncoupling of WASP and WIPF1, thereby permitting the regulation of actin filament nucleation and branching activity of the Arp2/3 complex. May mediate inhibitory effects of free fatty acids on insulin signaling by phosphorylating IRS1, which in turn blocks IRS1 tyrosine phosphorylation and downstream activation of the PI3K/AKT pathway. Phosphorylates MSN (moesin) in the presence of phosphatidylglycerol or phosphatidylinositol. Phosphorylates PDPK1 at 'Ser-504' and 'Ser-532' and negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylates CCDC88A/GIV and inhibits its guanine nucleotide exchange factor activity. Phosphorylates and activates LRRK1, which phosphorylates RAB proteins involved in intracellular trafficking.
Classification
- Family (Pfam)
- PF00130 C1_1, PF21494 PKC_C2, PF00069 Pkinase, PF00433 Pkinase_C
- InterPro
- AGC-kinase_C, C1-like_sf, C2_dom, C2_domain_sf, DAG/PE-bd, Kinase-like_dom_sf, nPKC_theta, PKC_DAG/PE, PKC_theta, Pkinase_C, Prot_kin_PKC_delta, Prot_kinase_dom, Protein_kinase_ATP_BS, Ser/Thr_kinase_AS
- Functional cluster
- Serine/Threonine Protein Kinases
Experimental structures · PDB · 8
- 1XJD X-ray 2.00A
- 2ENJ NMR
- 2ENN NMR
- 2ENZ NMR
- 2JED X-ray 2.32A
- 4Q9Z X-ray 2.60A
- 4RA5 X-ray 2.61A
- 5F9E X-ray 2.00A
A predicted model is available from AlphaFold.
Gene Ontology · 28
- GO:0034451 centriolar satellite
- GO:0005829 cytosol
- GO:0001772 immunological synapse
- GO:0005886 plasma membrane
- GO:0005524 ATP binding
- GO:0004699 diacylglycerol-dependent, calcium-independent serine/threonine kinase activity
- GO:0004672 protein kinase activity
- GO:0106310 protein serine kinase activity
- GO:0004674 protein serine/threonine kinase activity
- GO:0008270 zinc ion binding
- GO:0007411 axon guidance
- GO:0060326 cell chemotaxis
- GO:0038095 Fc-epsilon receptor signaling pathway
- GO:0002376 immune system process
- GO:0006954 inflammatory response
- GO:0035556 intracellular signal transduction
- GO:0006509 membrane protein ectodomain proteolysis
- GO:0046627 negative regulation of insulin receptor signaling pathway
- GO:0070233 negative regulation of T cell apoptotic process
- GO:0032740 positive regulation of interleukin-17 production
- GO:0032753 positive regulation of interleukin-4 production
- GO:0050870 positive regulation of T cell activation
- GO:2000318 positive regulation of T-helper 17 type immune response
- GO:2000570 positive regulation of T-helper 2 cell activation
- GO:0032206 positive regulation of telomere maintenance
- GO:0001558 regulation of cell growth
- GO:0006355 regulation of DNA-templated transcription
- GO:0090330 regulation of platelet aggregation
Drugs targeting this protein · 5
- GSK-690693 inhibitor
- SOTRASTAURIN inhibitor
- UCN-01 inhibitor
- CEP-2563 DIHYDROCHLORIDE inhibitor
- MIDOSTAURIN inhibitor
Related proteins · sequence + function similarity
- Protein kinase C theta type 0.99
- Protein kinase C theta type 0.99
- Protein kinase C delta type 0.94
- Protein kinase C delta type 0.94
- Protein kinase C delta type 0.94
- Protein kinase C delta type 0.94
- Protein kinase C-like 1 0.89
- Protein kinase C epsilon type 0.88
- Protein kinase C epsilon type 0.88
- Calcium-dependent protein kinase C 0.88
- Protein kinase C epsilon type 0.88
- Protein kinase C eta type 0.88
Co-cited proteins · studied together in the literature
- T-cell-specific surface glycoprotein CD28 1 shared papers
- Protein kinase C delta type 2 shared papers
- Bcl2-associated agonist of cell death 1 shared papers
- Caspase recruitment domain-containing protein 11 1 shared papers
- STE20/SPS1-related proline-alanine-rich protein kinase 1 shared papers
- E3 ubiquitin-protein ligase CBL-B 1 shared papers
- Girdin 1 shared papers
- Protein kinase C beta type 1 shared papers
- Insulin receptor substrate 1 1 shared papers
- Glutaredoxin-3 1 shared papers
- E3 ubiquitin-protein ligase DTX1 1 shared papers
- PRKCH upstream open reading frame 2 1 shared papers
Literature · 39 cited papers
- PKC isoforms activate LRRK1 kinase by phosphorylating conserved residues (Ser1064, Ser1074 and Thr1075) within the CORB GTPase domain. Biochem. J. · 2022
- Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs. Proc. Natl. Acad. Sci. U.S.A. · 2021
- Deltex1 promotes protein kinase Ctheta degradation and sustains Casitas B-lineage lymphoma expression. J. Immunol. · 2014
- An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome. J. Proteomics · 2014
- Protein kinase C-theta (PKCtheta) phosphorylates and inhibits the guanine exchange factor, GIV/Girdin. Proc. Natl. Acad. Sci. U.S.A. · 2013
- Toward a comprehensive characterization of a human cancer cell phosphoproteome. J. Proteome Res. · 2013
- A motif in the V3 domain of the kinase PKC-theta determines its localization in the immunological synapse and functions in T cells via association with CD28. Nat. Immunol. · 2011
- Protein kinase C-theta in platelet activation. FEBS Lett. · 2011
- System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation. Sci. Signal. · 2011
- Initial characterization of the human central proteome. BMC Syst. Biol. · 2011
- Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci. Signal. · 2009
- PKC-theta modulates the strength of T cell responses by targeting Cbl-b for ubiquitination and degradation. Sci. Signal. · 2009
- … and 27 more in the literature graph